Cargando…
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
BACKGROUND: The rising number of infections due to Severe Acute Respiratory Syndrome Coronavirus-2 (popularly known as COVID-19) has brought to the fore new antiviral drugs as possible treatments, including favipiravir. However, there is currently no data regarding the safety of this drug in patient...
Autores principales: | Ozsurekci, Yasemin, Oygar, Pembe Derin, Gürlevik, Sibel Laçinel, Kesici, Selman, Ozen, Seza, Kurt Sukur, Eda Didem, Gülhan, Bora, Topaloglu, Rezan, Bayrakci, Benan, Cengiz, Ali Bülent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140325/ https://www.ncbi.nlm.nih.gov/pubmed/34021797 http://dx.doi.org/10.1007/s00467-021-05111-x |
Ejemplares similares
-
The difference of the inflammatory milieu in MIS-C and severe COVID-19
por: Gurlevik, Sibel Lacinel, et al.
Publicado: (2022) -
Neurologic manifestations in children with COVID-19
por: Gürlevik, Sibel Laçinel, et al.
Publicado: (2022) -
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review
por: Laçinel Gürlevik, Sibel, et al.
Publicado: (2022) -
Management of acute abdomen during the active disease course of COVID-19 and multisystem inflammatory syndrome in children
por: Boybeyi-Turer, Ozlem, et al.
Publicado: (2022) -
Long-term kidney follow-up after pediatric acute kidney support therapy for children less than 15 kg
por: Gülçek, Ömer Nazım, et al.
Publicado: (2023)